Y23-20460-99717
2 vaccinations
12 coded responses
18 check-ins
12 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 170 / PA
- Registered
- 2021-10-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-01
Dose 1 — Pfizer-BioNTech
-
2021-10-02
Registered in v-safe
-
2021-10-02
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal pain, Asthma, Dyspnoea, Oral pruritus, Oropharyngeal pain, Pain in extremity, Pre-existing disease — Feeling: Good · Site: Itching · Joint pains, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Stabbing pains in abdomen and extremities, sore throat, SOB, asthma flare, intense itching in mouthMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 1MedDRA: Anaphylactic reaction, Dizziness, Dyspnoea, Increased upper airway secretion, Pharyngeal swelling, Pruritus, Tinnitus — Feeling: Fair · Fever · Be unable to work or attend schoolFree text: Anaphylactic anaphylactoid reaction: throat swelling, tinnitus, sob, itching, increase in mucus at throat, dizzyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Dyspnoea, Pre-existing disease, Tinnitus, Visual impairment — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I have MCAS. Tinnitus, dizzy, vision disturbance, sob.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion, Tremor — Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend schoolFree text: Congestion, shakingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-15
Survey response — day 14, dose 1MedDRA: Headache, Skin discolouration, Vasodilatation, Vein discolouration — Feeling: Good · Be unable to work or attend schoolFree text: Purplish looking mark-not quite a rash-on the forearm opposite vaccinated arm. Also veins on both arms popped out and turned dark blue-purple. Terrible headache.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
-
2021-10-23
Dose 2 — Pfizer-BioNTech
-
2021-10-29
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Lymphadenopathy, Onychalgia, Peripheral swelling, Purpura, Vasodilatation, Vein discolouration — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Purpura new capillaries and veins popped out and turned purple. SOB. Hands swollen, very painful nail beds. Swollen axilla lymph nodes.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-30
Survey response — day 7, dose 2MedDRA: Capillary disorder, Flushing, Onychalgia, Rash, Vasodilatation — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Veins on both arms and hands engorged and purple, new capillaries at skin surface, nail bed pain left hand. Rash both arms and flushed face.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-03
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-03
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-06
Survey response — day 14, dose 2MedDRA: Headache, Hypersensitivity, Muscle swelling, Myalgia, Pallor, Poor peripheral circulation, Vasculitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Vasculitis and accompanying headache, muscle pain, swelling. My fingers are blanched (pale) due to blood supply cut off. Still having allergic reactions, as well.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-10
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-13
Survey response — day 21, dose 2MedDRA: Cardiovascular disorder, Vasculitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Circulation problems Vascular inflammationMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-16
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-20
Survey response — day 28, dose 2MedDRA: Dermal cyst, Furuncle, Neck pain, Vascular wall discolouration — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cysts or boils on skin. Vascular discoloration. Neck pain.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-23
- 2021-11-27
-
2021-12-04
Survey response — day 42, dose 2MedDRA: Condition aggravated, Crohn's disease, Pre-existing disease, Vasculitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Inflammation flare after vaccine. Now my Crohn's disease has flared. My blood vessels are still inflamed.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-07
- 2022-01-24
-
2022-10-23
Survey response — 12 months, dose 2MedDRA: Asthenia, Hypoaesthesia, Neoplasm malignant, Pain, Paraesthesia, Raynaud's phenomenon, Rosacea, Vasculitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Cancer. Vasculitis. Lasting symptoms from first vaccine. Severe pain. Numbness. Tingling. Weakness. Raynauds. Rosecea.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-01 | Pfizer-BioNTech | No |
| 2 | 2021-10-23 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-29 | Successful 2021-11-03 |
Participant prefers to complete VAERS report online |
| 2021-10-30 | Successful 2021-11-03 |
Participant prefers to complete VAERS report online |
| 2021-11-06 | Successful 2021-11-10 |
Participant prefers to complete VAERS report online |
| 2021-11-13 | Successful 2021-11-16 |
Participant prefers to complete VAERS report online |
| 2021-11-20 | Successful 2022-10-25 |
Participant prefers to complete VAERS report online |
| 2021-12-04 | Successful 2022-10-25 |
Participant prefers to complete VAERS report online |
| 2022-10-23 | Successful 2022-10-25 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Stabbing pains in abdomen and extremities, sore throat, SOB, asthma flare, intense itching in mouth
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Anaphylactic anaphylactoid reaction: throat swelling, tinnitus, sob, itching, increase in mucus at throat, dizzy
Systemic reaction (other): I have MCAS. Tinnitus, dizzy, vision disturbance, sob.
Release 10 — day 7, dose 1
Systemic reaction (other): Congestion, shaking
Release 10 — day 14, dose 1
Symptoms: Purplish looking mark-not quite a rash-on the forearm opposite vaccinated arm. Also veins on both arms popped out and turned dark blue-purple. Terrible headache.
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Purpura new capillaries and veins popped out and turned purple. SOB. Hands swollen, very painful nail beds. Swollen axilla lymph nodes.
Release 10 — day 7, dose 2
Systemic reaction (other): Veins on both arms and hands engorged and purple, new capillaries at skin surface, nail bed pain left hand. Rash both arms and flushed face.
Release 10 — day 14, dose 2
Symptoms: Vasculitis and accompanying headache, muscle pain, swelling. My fingers are blanched (pale) due to blood supply cut off. Still having allergic reactions, as well.
Release 10 — day 21, dose 2
Symptoms: Circulation problems Vascular inflammation
Release 10 — day 28, dose 2
Symptoms: Cysts or boils on skin. Vascular discoloration. Neck pain.
Release 10 — day 42, dose 2
Symptoms: Inflammation flare after vaccine. Now my Crohn's disease has flared. My blood vessels are still inflamed.
Release 12 — 12 months, dose 2
Symptoms: Cancer. Vasculitis. Lasting symptoms from first vaccine. Severe pain. Numbness. Tingling. Weakness. Raynauds. Rosecea.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Cardiovascular disorder | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Crohn's disease | · | · | ✓ |
| SD | Dermal cyst | · | · | ✓ |
| SD | Furuncle | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Muscle swelling | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Neoplasm malignant | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pallor | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Poor peripheral circulation | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Raynaud's phenomenon | · | · | ✓ |
| SD | Rosacea | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SD | Vascular wall discolouration | · | · | ✓ |
| SD | Vasculitis | · | · | ✓ |
| SD | Vasodilatation | · | · | ✓ |
| SD | Vein discolouration | · | · | ✓ |
| SRO | Abdominal pain | · | · | ✓ |
| SRO | Anaphylactic reaction | · | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Capillary disorder | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Flushing | · | · | ✓ |
| SRO | Increased upper airway secretion | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Onychalgia | · | · | ✓ |
| SRO | Oral pruritus | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Peripheral swelling | · | · | ✓ |
| SRO | Pharyngeal swelling | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Purpura | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Tinnitus | · | · | ✓ |
| SRO | Tremor | · | · | ✓ |
| SRO | Vasodilatation | · | · | ✓ |
| SRO | Vein discolouration | · | · | ✓ |
| SRO | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release